Latest Wildcat Capital Management, LLC Stock Portfolio
Wildcat Capital Management, LLC Performance:
2025 Q1: -31.31%YTD: -31.31%2024: 26.93%
Performance for 2025 Q1 is -31.31%, and YTD is -31.31%, and 2024 is 26.93%.
About Wildcat Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Wildcat Capital Management, LLC reported an equity portfolio of $187.4 Millions as of 31 Mar, 2025.
The top stock holdings of Wildcat Capital Management, LLC are ULCC, RLX, . The fund has invested 65% of it's portfolio in FRONTIER GROUP HLDGS INC and 18.1% of portfolio in RLX TECHNOLOGY INC.
The fund managers got completely rid off GITLAB INC (GTLB) and PROCORE TECHNOLOGIES INC (PCOR) stocks. Wildcat Capital Management, LLC opened new stock positions in ACUREN CORP and CENTESSA PHARMACEUTICALS PLC (CNTA).
The top stock holdings of Wildcat Capital Management, LLC are ULCC, RLX, . The fund has invested 65% of it's portfolio in FRONTIER GROUP HLDGS INC and 18.1% of portfolio in RLX TECHNOLOGY INC.
The fund managers got completely rid off GITLAB INC (GTLB) and PROCORE TECHNOLOGIES INC (PCOR) stocks. Wildcat Capital Management, LLC opened new stock positions in ACUREN CORP and CENTESSA PHARMACEUTICALS PLC (CNTA).
Wildcat Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Wildcat Capital Management, LLC made a return of -31.31% in the last quarter. In trailing 12 months, it's portfolio return was -15.64%.
New Buys
| Ticker | $ Bought |
|---|---|
| acuren corp | 16,680,000 |
| centessa pharmaceuticals plc | 4,053,130 |
New stocks bought by Wildcat Capital Management, LLC
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| gitlab inc | -642,334 |
| procore technologies inc | -606,558 |
Wildcat Capital Management, LLC got rid off the above stocks
Sector Distribution
Wildcat Capital Management, LLC has about 65% of it's holdings in Industrials sector.
| Sector | % |
|---|---|
| Industrials | 65 |
| Others | 27.1 |
| Healthcare | 7.9 |
Market Cap. Distribution
Wildcat Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 72.4 |
| UNALLOCATED | 27.1 |
Stocks belong to which Index?
About 70.2% of the stocks held by Wildcat Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 70.2 |
| Others | 29.8 |
Wildcat Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Wildcat Capital Management, LLC
Wildcat Capital Management, LLC has 8 stocks in it's portfolio. ULCC proved to be the most loss making stock for the portfolio. URGN was the most profitable stock for Wildcat Capital Management, LLC last quarter.
Last Reported on: 02 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALLO | allogene therapeutics inc | 2.28 | 2,920,790 | 4,264,350 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals plc | 2.16 | 281,859 | 4,053,130 | new | |||
| GTLB | gitlab inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| KRON | kronos bio inc | 0.57 | 1,297,960 | 1,070,820 | unchanged | 0.00 | ||
| PCOR | procore technologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RLX | rlx technology inc | 18.10 | 18,046,200 | 33,926,800 | unchanged | 0.00 | ||
| ULCC | frontier group hldgs inc | 64.99 | 28,061,400 | 121,786,000 | unchanged | 0.00 | ||
| URGN | urogen pharma ltd | 2.92 | 495,606 | 5,481,400 | unchanged | 0.00 | ||
| acuren corp | 8.90 | 1,500,000 | 16,680,000 | new | ||||
| silexion therapeutics corp | 0.07 | 113,428 | 124,771 | unchanged | 0.00 | |||